WebDisclosure WebDisclosure
Basculer en Français
9904 Companies
199533 Keywords
130386 Articles
106040 Press releases
Headlines Articles Press releases H2o Therapeutics Remove
  1. Home
  2. Companies
  3. H2o Therapeutics
WebDisclosure
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 04/11/2024 at 16:05, 1 year 10 months ago

    H2o Therapeutics Launches FDA-approved "Foggy" Feature for Parkinson's Disease Management on Apple Watch

    FDA Approval Parkinson's Disease H2o Therapeutics Apple Watch Freezing Of Gait
  • BRIEF

    published on 04/11/2024 at 16:05, 1 year 10 months ago

    H2o Therapeutics lance la fonctionnalité « Foggy » approuvée par la FDA pour la gestion de la maladie de Parkinson sur Apple Watch

    Approbation De La FDA Apple Watch H2o Thérapeutique La Maladie De Parkinson Gel De La Démarche
  • PRESS RELEASE

    published on 04/11/2024 at 16:00, 1 year 10 months ago

    h2o Announces FDA Listing of Apple Watch-Based Cueing Feature 'Foggy' for Freezing of Gait in Parkinson's Disease

    h2o therapeutics introduces Foggy, a Class II Medical Device by the FDA, within the Parky app for Apple Watch to assist those with Parkinson's disease. Cueing strategy for freezing of gait
    Parkinson's Disease H2o Therapeutics Foggy Feature Parky App FDA Class II Medical Device
    Logo of H2o Therapeutics
Accesswire
  • Published on 02/20/2026 at 18:30, 12 minutes ago

    Sparta Updates Delay in Filing Annual Financial Statements

  • Published on 02/20/2026 at 15:45, 2 hours 57 minutes ago

    Revolve Announces Closing of Initial US$10 Million Advance on Strategic Financing With Callaway

  • Published on 02/20/2026 at 14:30, 4 hours 12 minutes ago

    Norse Gold Announces Application for Reactivation to TSX-V, Private Placement Financing and Stock Options Grant

  • Published on 02/20/2026 at 14:08, 4 hours 34 minutes ago

    Datavault AI Announces Anticipated Launch of Josh Gibson Stablecoin and Josh Gibson NIL Strategies for Its Forthcoming NIL Exchange

  • Published on 02/20/2026 at 14:00, 4 hours 42 minutes ago

    Nextech3D.ai's Eventdex Platform Powers AI Matchmaking for the SBA's CT Business Matchmaker Event Featuring Government Agencies and Major Prime Contractors

View all ACCESSWIRE
EQS Group
  • Published on 02/20/2026 at 18:36, 5 minutes ago

    EQS-Adhoc: innoscripta SE: Management Board Proposes Dividend of EUR 4.00 per Share

  • Published on 02/20/2026 at 18:31, 10 minutes ago

    Fuller, Smith & Turner PLC: Transaction in own shares

  • Published on 02/20/2026 at 18:23, 18 minutes ago

    POS-Transaction in Own Shares

  • Published on 02/20/2026 at 18:00, 42 minutes ago

    Leclanché conclut un accord de financement d’un montant de CHF 16,7 millions pour soutenir ses opérations à court terme

  • Published on 02/20/2026 at 18:00, 42 minutes ago

    Leclanché Secures Financing Arrangement in the amount of CHF 16.7 million to Support Near-Term Operations

View all EQS
Les Echos
  • Published on 02/20/2026 at 18:00, 42 minutes ago

    TERACT - Termination of liquidity agreement

  • Published on 02/20/2026 at 18:00, 42 minutes ago

    TERACT - Résiliation du contrat de liquidité

  • Published on 02/20/2026 at 17:35, 1 hour 7 minutes ago

    CHIFFRE D'AFFAIRES 2025

  • Published on 02/20/2026 at 09:28, 9 hours 14 minutes ago

    Déclaration du nombre d'actions composant le capital social et du nombre total de droits de vote au 31 janvier 2026

  • Published on 02/20/2026 at 09:28, 9 hours 14 minutes ago

    Statement about the number of shares composing the share capital and the number of voting rights as of January 31, 2026

View all LES ECHOS COMFI WIRE

With webdisclosure.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

©Dissemination technology Webdisclosure.com - copyright 2026 SYMEX ECONOMICS all rights reserved

WebDisclosure

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

Contact Authors Cookies policy Terms and conditions Privacy policy